Onderneming NicOx SA Euronext Paris
Aandelen
NCOX
FR0000074130
Farmaceutische producten
Vakgebied
Verkoop per activiteit
EUR in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Pharmaceutical
100,0
%
| 5 | 100,0 % | 7 | 100,0 % | +31,69% |
Verkoop per regio
EUR in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
France, United States and Italy
100,0
%
| - | - | 7 | 100,0 % | - |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Gavin M. Spencer
CEO | Chief Executive Officer | 53 | 01-01-05 |
Michele Garufi
FOU | Founder | 70 | 15-02-96 |
Sandrine Gestin
DFI | Director of Finance/CFO | 56 | 01-01-99 |
Doug Hubatsch
CTO | Chief Tech/Sci/R&D Officer | - | 13-12-21 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Les Kaplan
BRD | Director/Board Member | 73 | 01-10-14 |
Michele Garufi
FOU | Founder | 70 | 15-02-96 |
Chairman | 73 | 16-06-10 | |
Gavin M. Spencer
CEO | Chief Executive Officer | 53 | 01-01-05 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 50 170 498 | 46 850 128 ( 93,38 %) | 288 965 ( 0,5760 %) | 93,38 % |
Participaties
Naam | Aandelen | % | Totale waarde |
---|---|---|---|
NICOX SA 0.49% | 311 067 | 0.49% | 70 012 $ |
Bedrijfsgegevens
![Adres NicOx SA(NCOX)](https://cdn.zonebourse.com/static/address/4780.png)
Sector
Verkoop per regio
Vaira. 1 jan. | Kapi. | |
---|---|---|
+5,97% | 71,83 mld. | |
+23,57% | 9,56 mld. | |
+30,09% | 4,85 mld. | |
-21,31% | 4,48 mld. | |
+24,78% | 3,9 mld. | |
+11,03% | 2,01 mld. | |
-0,84% | 1,99 mld. | |
-36,28% | 1,89 mld. | |
-43,19% | 1,77 mld. |